TY - JOUR
T1 - Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance
AU - Revelo, Xavier S.
AU - Ghazarian, Magar
AU - Chng, Melissa Hui Yen
AU - Luck, Helen
AU - Kim, Justin H.
AU - Zeng, Kejing
AU - Shi, Sally Y.
AU - Tsai, Sue
AU - Lei, Helena
AU - Kenkel, Justin
AU - Liu, Chih Long
AU - Tangsombatvisit, Stephanie
AU - Tsui, Hubert
AU - Sima, Corneliu
AU - Xiao, Changting
AU - Shen, Lei
AU - Li, Xiaoying
AU - Jin, Tianru
AU - Lewis, Gary F.
AU - Woo, Minna
AU - Utz, Paul J.
AU - Glogauer, Michael
AU - Engleman, Edgar
AU - Winer, Shawn
AU - Winer, Daniel A.
N1 - Publisher Copyright:
© 2016 The Author(s)
PY - 2016/7/19
Y1 - 2016/7/19
N2 - Obesity-related inflammation of metabolic tissues, including visceral adipose tissue (VAT) and liver, are key factors in the development of insulin resistance (IR), though many of the contributing mechanisms remain unclear. We show that nucleic-acid-targeting pathways downstream of extracellular trap (ET) formation, unmethylated CpG DNA, or ribonucleic acids drive inflammation in IR. High-fat diet (HFD)-fed mice show increased release of ETs in VAT, decreased systemic clearance of ETs, and increased autoantibodies against conserved nuclear antigens. In HFD-fed mice, this excess of nucleic acids and related protein antigens worsens metabolic parameters through a number of mechanisms, including activation of VAT macrophages and expansion of plasmacytoid dendritic cells (pDCs) in the liver. Consistently, HFD-fed mice lacking critical responders of nucleic acid pathways, Toll-like receptors (TLR)7 and TLR9, show reduced metabolic inflammation and improved glucose homeostasis. Treatment of HFD-fed mice with inhibitors of ET formation or a TLR7/9 antagonist improves metabolic disease. These findings reveal a pathogenic role for nucleic acid targeting as a driver of metabolic inflammation in IR.
AB - Obesity-related inflammation of metabolic tissues, including visceral adipose tissue (VAT) and liver, are key factors in the development of insulin resistance (IR), though many of the contributing mechanisms remain unclear. We show that nucleic-acid-targeting pathways downstream of extracellular trap (ET) formation, unmethylated CpG DNA, or ribonucleic acids drive inflammation in IR. High-fat diet (HFD)-fed mice show increased release of ETs in VAT, decreased systemic clearance of ETs, and increased autoantibodies against conserved nuclear antigens. In HFD-fed mice, this excess of nucleic acids and related protein antigens worsens metabolic parameters through a number of mechanisms, including activation of VAT macrophages and expansion of plasmacytoid dendritic cells (pDCs) in the liver. Consistently, HFD-fed mice lacking critical responders of nucleic acid pathways, Toll-like receptors (TLR)7 and TLR9, show reduced metabolic inflammation and improved glucose homeostasis. Treatment of HFD-fed mice with inhibitors of ET formation or a TLR7/9 antagonist improves metabolic disease. These findings reveal a pathogenic role for nucleic acid targeting as a driver of metabolic inflammation in IR.
UR - http://www.scopus.com/inward/record.url?scp=84978543398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978543398&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2016.06.024
DO - 10.1016/j.celrep.2016.06.024
M3 - Article
C2 - 27373163
AN - SCOPUS:84978543398
SN - 2211-1247
VL - 16
SP - 717
EP - 730
JO - Cell reports
JF - Cell reports
IS - 3
ER -